Nicotine replacement gums or popular drugs prescribed to help people quit smoking may not pose serious heart risks in users, according to a study.
In recent years, there have been concerns that some smoking cessation products may have serious cardiovascular risks.But in the largest analysis of side effects of three major smoking cessation products, serious heart events didn't increase with nicotine replacement gums and patches, the nicotine addiction treatment Chantix, and the anti-depressant Wellbutrin, reported Xinhua citing a study published Monday in the American Heart Association journal.
The study found that overall, smoking cessation is associated with improved cardiovascular health, increased life expectancy, improved quality of life and reduced healthcare costs for smoking-associated conditions."Undoubtedly, the benefits of quitting smoking outweigh any potential risks from smoking cessation therapies," said Edward Mills, study co-author and associate professor of medicine at Stanford University and Canada Research Chair at the University of Ottawa.
Should Machines Decide Who Lives And Dies In A War? Ex-CIA Chief Answers
Kriti Sanon Says Instagram Has No Option To Report AI-Generated Images Of Her
What Anthropic, Monks And The Cusp Of Consciousness Teach About Tomorrow
Nikhil Kamath's Big AI Bet: Why India Should Look Beyond Silicon Valley
When Will India Get Its Own Apple, Samsung? Ashwini Vaishnaw Reveals Timeline
Neeru Saini On Fitness, Focus & Her Love for Churma!
NDTV Lifeline- Himanshu Saini on the Secret to Eating Well: More Greens, Healthier Desserts
Hockey Champions Savita Punia & Neha Goel on Fitness, Recovery & The Meaning of Health
Millets: The Superfood That's Good for You and the Planet
Yoga, Millets, Vaccines: S Jaishankar On How India Is Building Stronger Ties | NDTV World Summit
The study found that overall, smoking cessation is associated with improved cardiovascular health, increased life expectancy, improved quality of life and reduced healthcare costs for smoking-associated conditions."Undoubtedly, the benefits of quitting smoking outweigh any potential risks from smoking cessation therapies," said Edward Mills, study co-author and associate professor of medicine at Stanford University and Canada Research Chair at the University of Ottawa.









